What is MRD? Measurable residual disease, or MRD, refers to the low numbers of malignant cells that can persist in the body during or after treatment, even when conventional assessments indicate remission. These remaining cells carry the risk of driving disease recurrence and are now widely regarded as a meaningful biomarker in hematologic malignancies. As … Continue reading NGS MRD Solutions for Hematologic Malignancies